OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of healthcare technology solutions, has scheduled its third quarter 2024 conference call for November 13, 2024, at 4:30 p.m. Eastern Time. The company will discuss financial results for the quarter ended September 30, 2024, which will be released before the call. Management will host the call followed by a Q&A session. The call will be accessible via toll-free and international numbers, with a webcast option available. A replay will be accessible for 12 months through the company's investor relations website.
OptimizeRx Corp. (Nasdaq: OPRX), un fornitore leader di soluzioni tecnologiche per la salute, ha programmato la sua conferenza telefonica del terzo trimestre 2024 per il 13 novembre 2024, alle 16:30, ora orientale. L'azienda discuterà i risultati finanziari per il trimestre conclusosi il 30 settembre 2024, che saranno pubblicati prima della chiamata. La direzione ospiterà la chiamata seguita da una sessione di domande e risposte. La chiamata sarà accessibile tramite numeri verdi e internazionali, con un'opzione di webcast disponibile. Una registrazione sarà accessibile per 12 mesi tramite il sito web delle relazioni con gli investitori dell'azienda.
OptimizeRx Corp. (Nasdaq: OPRX), un proveedor líder de soluciones de tecnología en salud, ha programado su llamada de conferencia del tercer trimestre de 2024 para el 13 de noviembre de 2024 a las 4:30 p.m. hora del Este. La compañía discutirá los resultados financieros del trimestre que terminó el 30 de septiembre de 2024, que se anunciarán antes de la llamada. La administración será la anfitriona de la llamada, seguida de una sesión de preguntas y respuestas. La llamada será accesible a través de números gratuitos e internacionales, con una opción de webcast disponible. Se podrá acceder a una repetición durante 12 meses a través del sitio web de relaciones con inversores de la empresa.
OptimizeRx Corp. (Nasdaq: OPRX)는 의료 기술 솔루션의 선도적 제공업체로서 2024년 3분기 컨퍼런스 콜을 2024년 11월 13일 동부 표준시 오후 4시 30분에 예약했습니다. 회사는 2024년 9월 30일에 종료된 분기의 재무 결과를 논의할 예정이며, 콜 전에 발표될 것입니다. 경영진이 전화를 주최하며, 이어 질문과 답변 시간이 있습니다. 이 통화는 무료 및 국제 번호를 통해 접근 가능하며, 웹 캐스트 옵션도 제공됩니다. 이 회사의 투자자 관계 웹사이트를 통해 12개월 동안 재청취할 수 있습니다.
OptimizeRx Corp. (Nasdaq: OPRX), un fournisseur de solutions technologiques de santé de premier plan, a programmé sa conférence téléphonique du troisième trimestre 2024 pour le 13 novembre 2024 à 16h30, heure de l'Est. L'entreprise discutera des résultats financiers pour le trimestre se terminant le 30 septembre 2024, qui seront publiés avant l'appel. La direction animera l'appel suivi d'une session de questions-réponses. L'appel sera accessible par des numéros gratuits et internationaux, avec une option de webdiffusion disponible. Un enregistrement sera accessible pendant 12 mois sur le site web des relations avec les investisseurs de l'entreprise.
OptimizeRx Corp. (Nasdaq: OPRX), ein führender Anbieter von Technologielösungen im Gesundheitswesen, hat seine Konferenzschaltung für das dritte Quartal 2024 für den 13. November 2024 um 16:30 Uhr Eastern Time geplant. Das Unternehmen wird die finanziellen Ergebnisse für das am 30. September 2024 abgeschlossene Quartal besprechen, die vor dem Anruf veröffentlicht werden. Das Management wird den Anruf moderieren, gefolgt von einer Fragerunde. Der Anruf ist über gebührenfreie und internationale Nummern sowie über eine Webcast-Option zugänglich. Eine Aufzeichnung wird 12 Monate lang über die Investor Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Wednesday, November 13, 2024, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2024. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: | Wednesday, November 13, 2024 |
| Time: | 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) |
| Toll Free: | 1-844-825-9789 |
| International: | 1-412-317-5180 |
| Conference ID: | 10193688 |
| Call Me Link: | https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg== |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1693210&tp_key=d77879d241 |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at http://www.optimizerx.com/investors.
About OptimizeRx
OptimizeRx provides trailblazing technology that fosters care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the healthcare journey. With the ability to synchronize messaging across 2 million healthcare providers and over 240 million adults across a multitude of digital channels including a proprietary point-of-care network, OptimizeRx is changing the way life sciences engages with customers.
For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com
Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com
FAQ
When is OptimizeRx (OPRX) releasing Q3 2024 earnings?
How can I access OptimizeRx (OPRX) Q3 2024 earnings call?
How long will OptimizeRx (OPRX) Q3 2024 earnings call replay be available?
